Several Republican senators joined Democrats in calling for reining in a tool that drugmakers use to extend their monopolies.

Republicans and Democrats bashed the technique, called “evergreening,” during a hearing Tuesday on high drug prices in the Senate Health, Education, Labor and Pensions Committee.

Recommended Stories

Congress takes aim again at pharmaceutical giant over patent-stacking for brand-name drugs

Big Pharma’s patent monopoly is stealing your next paycheck — and driving up costs

Big Tech’s patent battering ram isn’t lowering drug prices